Takeda sells off another OTC asset for $2.2B

Takeda sold its Japanese-focused consumer healthcare business to private equity firm Blackstone Group for $2.2 billion, the latest in several similar transactions the company has executed, Endpoints News reports.

What you should know:

1. Takeda spun off several of its non-core business lines after closing its deal for Shire in 2019. The company has committed to selling $10 billion of its non-core assets.

2. Takeda acquired Shire for $62 billion, which made it one of the most indebted companies in the world.

3. Blackstone acquired a portfolio of drugs that made a reported $567 million (60 billion yen) in 2019.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast